Cytokinetics, Incorporated
Status: Publicly traded
Direct answer
Cytokinetics, Incorporated is publicly traded on NASDAQ under the ticker CYTK.
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule...
Can you invest in Cytokinetics, Incorporated?
Yes. Cytokinetics, Incorporated is publicly traded on NASDAQ under the ticker CYTK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Cytokinetics, Incorporated
Detailed equity research is provided by MarketSnap.